Mesenchymal stem cells in renal function recovery after acute kidney injury: Use of a differentiating agent in a rat model

Cell Transplantation

Volumn 20, Issue 8, 2011, Pages 1193-1208

  la Manna, Gaetano ^a,b   Bianchi, Francesca ^a,b   Cappuccilli, Maria ^a,b   Cenacchi, Giovanna ^a,b   Tarantino, Lucia ^a,b   Pasquinelli, Gianandrea ^a,b   Valente, Sabrina ^a,b   Bella, Elena Della ^a,b   Cantoni, Silvia ^a,b   Claudia, Cavallini ^a,b   Neri, Flavia ^b   Tsivian, Matvey ^b   Nardo, Bruno ^b   Ventura, Carlo ^a   Stefoni, Sergio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Acute kidney injury (AKI); Mesenchymal stem cells (MSCs); Renal cell biology; Renal function; Stem cells

Indexed keywords

BUTYRIC ACID;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMICAL COMPOSITION; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RELEASE; ELECTRON MICROSCOPY; FETUS MEMBRANE; HISTOPATHOLOGIC SKIN REACTION; HUMAN; HUMAN CELL; INFLAMMATION; INJURY SEVERITY; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; MESENCHYMAL STEM CELL; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; RAT; REPERFUSION;

ACUTE KIDNEY INJURY; ANIMALS; BUTYRIC ACID; CELL DIFFERENTIATION; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION;

RATTUS;

EID: 80855143912     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X543394     Document Type: Article

References (53)

1. Aggarwal, S.; Pittenger, M. F. Human mesenchymal stem cells modulate allogenic immune cell response. Blood 19: 1815-1822; 2005.
2. Bartholomew, A.; Sturgeon, C.; Siatskas, M.; Ferrer, K.; McIntosh, K.; Patil, S.; Hardy, W.; Devine, S.; Ucker, D.; Deans, R.; Moseley, A.; Hoffman, R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30:42-48; 2002.
3. Bi, B.; Schmitt, R.; Israilova, M.; Nishio, H.; Cantley, L. G. Stromal cells protect against acute tubular injury via an endocrine effect. J. Am. Soc. Nephrol. 18:2486-2496; 2007.
4. Blandini, F.; Cova, L.; Armentero, M.; Zennaro, E.; Levandis, G.; Bossolasco, P.; Calzarossa, C.; Mellone, M.; Giuseppe, B.; Deliliers, G. L.; Polli, E.; Nappi, G.; Silani, V. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant. 19(2):203-217; 2010.
5. Bonventre, J. V.; Zuk, A. Ischemic acute renal failure: An inflammatory disease? Kidney Int. 66:480-485; 2004.
6. Chen, L. B.; Jiang, X. B.; Yang, L. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J. Gastroenterol. 10(20):3016-3020; 2004.
7. Chhabra, P.; Brayman, K. L. The use of stem cells in kidney disease. Curr. Opin. Organ Transplant. 14:72-78; 2009.
8. Frübeck, G. Intracellular signalling pathways activated by leptin. Biochem. J. 393:7-20; 2006.
9. Geffner, L. F.; Santacruz, P.; Izurieta, M.; Flor, L.; Maldonado, B.; Auad, A. H.; Montenegro, X.; Gonzales, R.; Silva, F. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: Comprehensive case studies. Cell Transplant. 17(12):1277-1293; 2008.
10. Heldin, C. H.; Westermark, B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79(4):1283-1316; 1999.
11. Herrera, M. B.; Bussolati, B.; Bruno, S.; Morando, L.; Mauriello-Romanazzi, G.; Sanavio, F.; Stamenkovic, I.; Biancone, L.; Camussi, G. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int. 72(4):430-441; 2007.
12. Humphreys, B. D.; Bonventre, J. V. Mesenchymal stem cells in acute kidney injury. Annu. Rev. Med. 59:311325; 2008.
13. In't Anker, P. S.; Scherjon, S. A.; Kleijburg-van der Keur, C.; de Groot-Swings, G. M.; Claas, F. H.; Fibbe, W. E.; Kanhai, H. H. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22(7): 1338-1345; 2004.
14. Jiang, X. X.; Zhang, Y.; Liu, B.; Zhang, S. X.; Wu, Y.; Yu, X. D.; Mao, N. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105(10):4120-4126; 2005.
15. Karpinski, J.; Lajoie, G.; Cattran, D.; Fenton, S.; Zaltz-man, J.; Cardella, C.; Cole, E. Outcome of kidney transplantation from high-risk donors is determined by both structure and function. Transplantation 67(8):1162-1167; 1999.
16. Kellum, J. A. Acute kidney injury. Crit. Care Med. 36(Suppl. 4):S141-S145; 2008.
17. Klyushnenkova, E.; Mosca, J. D.; Zernetkina, V.; Majumdar, M. K.; Beggs, K. J.; Simonetti, D. W.; Deans, R. J.; McIntosh, K. R. T cell responses to allogeneic human mesenchymal stem cells: Immunogenicity, tolerance, and suppression. J. Biomed. Sci. 12:47-57; 2005.
18. Knudson, W.; Chow, G.; Knudson, C. B. CD44-mediated uptake and degradation of hyaluronan. Matrix Biol. 21(1): 15-23; 2002.
19. Kozian, D. H.; Ziche, M.; Augustin, H. G. The activin- binding protein follistatin regulates autocrine endothelial cell activity and induces angiogenesis. Lab. Invest. 76(2): 267-276; 1997.
20. Lameire, N.; Van Biesen, W.; Vanholder, R. Acute renal failure. Lancet 365:417-430; 2005.
21. Lazzeri, E.; Crescioli, C.; Ronconi, E.; Mazzinghi, B.; Sagrinati, C.; Netti, G. S.; Angelotti, M. L.; Parente, E.; Ballerini, L.; Cosmi, L.; Maggi, L.; Gesualdo, L.; Rotondi, M.; Annunziato, F.; Maggi, E.; Lasagni, L.; Serio, M.; Romagnani, S.; Vannelli, G. B.; Romagnani, P. Regenerative potential of embryonic renal multipotent progenitors in acute renal failure. J. Am. Soc. Nephrol. 18:31283138; 2007.
22. Le Blanc, K.; Tammik, C.; Rosendahl, K.; Zetterberg, E.; Ringdén, O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol. 31:890-896; 2003.
23. Le Blanc, K.; Tammik, L.; Sundberg, B.; Haynesworth, S. E.; Ringdén, O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 57:11-20; 2003.
24. Maeshima, A.; Zhang, Y. Q.; Nojima, Y.; Naruse, T.; Kojima, I. Involvement of the activin-follistatin system in tubular regeneration after renal ischemia in rats. J. Am. Soc. Nephrol. 12:1685-1695; 2001.
25. Marks, P. A.; Richon, V. M.; Rifkind, R. A. Histone deacetylase inhibitors: Inducers of differentiation or apo-ptosis of transformed cells. J. Natl. Cancer Inst. 92:1210-1216; 2000.
26. Matsumoto, K.; Nakamura, T. Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases. Kidney Int. 59(6):2023-2038; 2001.
27. Metcalfe, W.; Simpson, M.; Khan, I. H.; Prescott, G. J.; Simpson, K.; Smith, W. C. S.; MacLeod, A. M. Acute renal failure requiring renal replacement therapy: Incidence and outcome. QJM 95:579-583; 2002.
28. Morigi, M.; Imberti, B.; Zoja, C.; Corna, D.; Tomasoni, S.; Abbate, M.; Rottoli, D.; Angioletti, S.; Benigni, A.; Perico, N.; Alison, M.; Remuzzi, G. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J. Am. Soc. Nephrol. 15:1794-1804; 2004.
29. Poulsom, R.; Forbes, S. J.; Hodivala-Dilke, K.; Ryan, E.; Wyles, S.; Navaratnarasah, S.; Jeffery, R.; Hunt, T.; Alison, M.; Cook, T.; Pusey, C.; Wright, N. A. Bone marrow contributes to renal parenchymal turnover and regeneration. J. Pathol. 195:229-235; 2001.
30. Qian, H.; Yang, H.; Xu, W.; Yan, Y.; Chen, Q.; Zhu, W.; Cao, H.; Yin, Q.; Zhou, H.; Mao, F.; Chen, Y. Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells. Int. J. Mol. Med. 22(3):325-332; 2008.
31. Sagrinati, C.; Netti, G. S.; Mazzinghi, B.; Lazzeri, E.; Liotta, F.; Frosali, F.; Ronconi, E.; Meini, C.; Gacci, M.; Squecco, R.; Carini, M.; Gesualdo, L.; Francini, F.; Maggi, E.; Annunziato, F.; Lasagni, L.; Serio, M.; Romagnani, S.; Romagnani, P. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J. Am. Soc. Nephrol. 17: 2443-2456; 2006.
32. Snykers, S.; De Kock, J.; Rogiers, V.; Vanhaecke, T. In vitro differentiation of embryonic and adult stem cells into hepatocytes: State of the art. Stem Cells 27(3):577-605; 2009.
33. Sotiropoulou, P. A.; Perez, S. A.; Salagianni, M.; Baxe- vanis, C. N.; Papamichail, M. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24(2):462-471; 2006.
34. Stappenbeck, T. S.; Miyoshi, H. The role of stromal stem cells in tissue regeneration and wound repair. Science 324(5935):1666-1669; 2009.
35. Thomas, J.; Liu, F.; Link, D. C. Mechanisms of mobilization of hematopoietic progenitors with granulocyte colony-stimulating factor. Curr. Opin. Hematol. 9:183-189; 2002.
36. Thurston, G. Role of angiopoietins and tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res. 314(1):61-68; 2003.
37. Tögel, F.; Hu, Z.; Weiss, K.; Isaac, J.; Lange, C.; Westen-felder, C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am. J. Physiol. Renal Physiol. 289:F31-F42; 2005.
38. Tögel, F.; Weiss, K.; Yang, Y.; Hu, Z.; Zhang, P.; Westenfelder, C. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am. J. Physiol. Renal Physiol. 292:F1626-F1635; 2007.
39. Tögel, F.; Zhang, P.; Hu, Z.; Westenfelder, C. VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury. J. Cell. Mol. Med. 13(8B):2109-2114; 2009.
40. Udy, A.; O'Donoghue, S.; D'Intini, V.; Healy, H.; Lipman, J. Point of care measurement of plasma creatinine in critically ill patients with acute kidney injury. Anaesthesia 64:403-407; 2009.
41. Ventura, C.; Cantoni, S.; Bianchi, F.; Lionetti, V.; Caval- lini, C.; Scarlata, I.; Foroni, L.; Maioli, M.; Bonsi, L.; Alviano, F.; Fossati, V.; Bagnara, G. P.; Pasquinelli, G.; Recchia, F. A.; Perbellini, A. Hyaluronan mixed esters of butyric and retinoic acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts. J. Biol. Chem. 282(19):14243-14251; 2007.
42. Ventura, C.; Maioli, M.; Asara, Y.; Santoni, D.; Scarlata, I.; Cantoni, S.; Perbellini, A. Butyric and retinoic mixed esters of hyaluronan. J. Biol. Chem. 279:23574-23579; 2004.
43. Waikar, S. S.; Curhan, G. C.; Wald, R.; McCarthy, E. P.; Chertow, G. M. Declining mortality in patients with acute renal failure, 1988 to 2002. J. Am. Soc. Nephrol. 17: 1143-1150; 2006.
44. Wan, C. D.; Cheng, R.; Wang, H. B.; Liu, T. Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation model. Hepatobiliary Pancreat. Dis. Int. 7(1):29-33; 2008.
45. Wong, C. Y.; Cheong, S. K.; Mok, P. L.; Leong, C. F. Differentiation of human mesenchymal stem cells into mesangial cells in post-glomerular injury murine model. Pathology 40(1):51-57; 2008.
46. Woodfin, A.; Voisin, M. B.; Nourshargh, S. PECAM-1: A multi-functional molecule in inflammation and vascular biology. Arterioscler. Thromb. Vasc. Biol. 27(12):2514-2523; 2007.
47. Yang, J.; Liu, Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J. Am. Soc. Nephrol. 13:96-107; 2002.
48. Yen, B. L.; Huang, H. I.; Chien, C. C.; Jui, H. Y.; Ko, B. S.; Yao, M.; Shun, C. T.; Yen, M. L.; Lee, M. C.; Chen, Y. C. Isolation of multipotent cells from human term placenta. Stem Cells 23(1):3-9; 2005.
49. Yokoo, T.; Kawamura, T.; Kobayashi, E. Stem cells for kidney repair: Useful tool for acute renal failure? Kidney Int. 74(7):847-849; 2008.
50. Zhang, W.; Qin, C.; Zhou, Z. M. Mesenchymal stem cells modulate immune responses combined with cyclosporine in a rat renal transplantation model. Transplant. Proc. 39(10):3404-3408; 2007.
51. Zhang, X.; Jiao, C.; Zhao, S. Role of mesenchymal stem cells in immunological rejection of organ transplantation. Stem Cell Rev. 5(4):402-409; 2009.
52. Zhang, Y.; Woodward, V. K.; Shelton, J. M.; Richardson, J. A.; Zhou, X. J.; Link, D.; Kielar, M. L.; Jeyarajah, R.; Lu, C. Y. Ischemia-reperfusion induces G-CSF gene expression by renal medullary thick ascending limb cells in vivo and in vitro. Am. J. Physiol. Renal Physiol. 286(6):F1193-F1201; 2004.
53. Zhou, H. P.; Yi, D. H.; Yu, S. Q.; Sun, G. C.; Cui, Q.; Zhu, H. L.; Liu, J. C.; Zhang, J. Z.; Wu, T. J. Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft. Transplant. Proc. 38(9):3046-3051; 2006.